Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01125696Phase 2Completed
A Phase 2 trial of tenofovir in human immunodeficiency virus infection (HIV), hepatitis B (HBV), sponsored by Centers for Disease Control and Prevention. Started May 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01125696.